发明名称 |
Muscarinic agonists |
摘要 |
Compounds and methods are provided for the treatment of disease conditions in which modification of cholinergic, especially muscarinic m1, m4, or both m1 and m4, receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment. |
申请公布号 |
AU5919001(A) |
申请公布日期 |
2001.11.12 |
申请号 |
AU20010059190 |
申请日期 |
2001.04.27 |
申请人 |
ACADIA PHARMACEUTICALS, INC. |
发明人 |
CARL-MAGNUS A. ANDERSSON;BO LENNART M. FRIBERG;NIELS SKJAERBAEK;TRACY SPALDING;ALLAN K. ULDAM |
分类号 |
C07D249/18;A61K31/4439;A61K31/52;A61P25/02;A61P25/04;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P27/06;C07C271/28;C07D261/20;C07D333/54;C07D401/06;C07D405/06;C07D407/04;C07D409/04;C07D409/06;C07D413/06;C07D413/12;C07D417/06;C07D471/04;C07D473/00;C07D487/04;C07F7/22 |
主分类号 |
C07D249/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|